SCHEMBL15435518

SCHEMBL15435518

COCc1c(-c2ccc(NC(=O)NNc3cc(C(F)(F)F)ccc3F)cc2)c2c(N)ncnn2c1CN1CCN(C(C)=O)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 9/20 0.69
FLT3 P36888 5/20 0.69
FRK P42685 3/20 0.69
MAPK9 P45984 3/20 0.69
RPS6KA3 P51812 3/20 0.69
MAP4K2 Q12851 3/20 0.69
RET P07949 3/20 0.69
PRKCD Q05655 2/20 0.69
BCR P11274 1/20 0.69
DDR1 Q08345 1/20 0.69
TNK1 Q13470 1/20 0.69
RPS6KA1 Q15418 1/20 0.69
MAP3K11 Q16584 1/20 0.69
DDR2 Q16832 1/20 0.69
RPS6KA6 Q9UK32 1/20 0.69
FGFR3 P22607 7/20 0.49
KDR P35968 9/20 0.45
FLT1 P17948 6/20 0.45
KIT P10721 5/20 0.45
TEK Q02763 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275510 0.95 FGFR1 (0.75) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL275605 0.90 FGFR1 (0.76) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL277316 0.90 FLT3 (0.77) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL328094 0.88 FLT3 (0.64) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL275980 0.88 FLT3 (0.88) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL276209 0.87 FLT3 (0.72) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL276864 0.86 FGFR1 (0.60) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL274856 0.85 FLT3 (0.70) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL275969 0.85 FLT3 (0.72) FGFR1FLT3FRKMAPK9RPS6KA3
SCHEMBL276060 0.84 FLT3 (0.68) FGFR1FLT3FRKMAPK9RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957077-B1 SUBSTITUTED 4-AMINO-PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER HEALTHCARE LLC (US) 2014-01-22 EP disclosed